Our readers have been curious whether there will be any “pure-play hemp” IPOs on the horizon. Today we’re going to tell you why that’s not likely – and how to unlock the most significant gains the cannabis industry has to offer.

With the introduction of the 2018 Farm Bill, U.S hemp cultivation is finally legal.

That led to a flood of questions from our readers. Folks wanted to know if there were any “pure-play hemp” IPOs on the horizon.

That’s fair.

I’ve been upfront that my goal with the National Institute for Cannabis Investors is to provide you all with the information, access, and guidance needed to make a fortune in cannabis.

But I have to be frank: I don’t see a pure-play hemp pick in our portfolio anytime soon.

Right now, hemp is a big buzzword on Wall Street, just like blockchain was in 2017. To cash in on the craze, Long Island Ice Tea entered the crypto market and changed its name to Long Blockchain Corp.

The stock price exploded 341% to $9.49 per share, thanks to the name change.

Do you know how much a share of Long Blockchain is worth today?

Less than 20 cents.

I’m not going to send you down a similar path, chasing returns from buzzwords on Wall Street.

Instead, I’m going to show you how to unlock the most significant gains the cannabis industry has to offer…

Here’s Where the Real Profits Are in the Cannabis Industry

The words “hemp” and “CBD” often are lumped together, but they are two separate markets. Hemp is a plant, and CBD is an extract from hemp plants.

The margins are tight selling the plant alone. Farmers have to pay land rent and insurance, buy and repair expensive equipment, and make sure they can make payroll each month.

It’s very difficult to scale in order to become a massive producer of any agricultural crop.

That means a pure-play hemp IPO – where you’re investing in a hemp farm – just isn’t going to make you enough money.

Revenue projections prove it.

If you want to beat Wall Street, if you want to trade like America’s elite, you need to have this one invaluable tool in your arsenal. Not only does it help you cut through the market noise, it also helps pinpoint the most lucrative profit opportunities in the game. And if you click here, we can show you how you can get this powerful investing tool at your fingertips.

The U.S. Hemp Industry netted $820 million in sales in 2017, and that’s only expected to climb to $1.9 billion in 2022, according to the Hemp Business Journal. That’s not enough to move the needle to mint an entirely new class of marijuana millionaires.

Now look.

I don’t want it to seem like I’m picking on the hemp industry. I’m just focusing on helping you folks turn your hard-earned money into a nest egg that gives you the peace of mind you deserve.

That’s why I’ve proclaimed 2019 as the “Year of CBD.”

There is a large backlog of companies that have been itching to make or sell products from hemp, and some already-successful companies are poised to make massive profits from feeding the demand. The best of those companies have been in our Cannabis Investor’s Report Model portfolio since this service launched in October 2018.

Within a few months, CBD will be available in a much larger variety of products. You will be able to choose among tinctures (currently the primary form of consumption), gummies, energy shots, nutrition bars, skin moisturizers, infused ingredients like honey, and more.

Throughout the year, I predict the demand for CBD products will at least triple to nearly $2 billion.

And keep in mind – this sector is still just in its infancy.

According to the Brightfield Group, the CBD sector could easily skyrocket to $22 billion by 2022.

That’s why, before the market takes off, we dug our heels in and found the best CBD play to make right now for long-term gains.

You can access that, and all the top cannabis picks in our portfolio, in the Cannabis Investor’s Report.

Remember that we’re only going to share cannabis picks that deserve to be in your portfolio.

As soon as I uncover the cream of the crop, you will be the first to know.

To your continued investment success,

Greg Miller
Executive Director, National Institute for Cannabis Investors

P.S. When you’re playing the marijuana market for huge gains, you have two choices… you could quickly get in and out of IPOs, potentially doubling or tripling your money in a matter of days or weeks… or you could invest for a few months and go for the potential 1,000% gains that are possible in this new market. The choice is yours. But you have to hurry. Just click here to learn more.


Comments

6 responses to “Why You Won’t See a Pure-Play Hemp IPO in Our Portfolio Anytime Soon”

  1. Bob,
    Hemp inc. is a microcap stock on the OTC exchange. It has a long way to go before analysts even consider covering it. I bought it early last year for 1 cent. Mainly because as a veteran I like what they are offering veterans in their kins village project. I sold half my position when the stock hit 6 cents. I am way ahead profit wise and will hold it for the long term. I have nothing to lose. My only issue with them is the large number of outstanding shares they have, 754 million. I suspect they will have to do a reverse split to increase the price. Eventually they will be a player if you don’t mind waiting.

  2. May not be related to the subject but Pa. Is submitting plans to allow for industrial hemp production. Article was in the paper today. Is this good or bad for hemp investments? Thanks.

  3. How come NICI never mentions Acreage Holdings? John Boehner is on their BOD …. Why isn’t Acreage a decent bet?

Leave a Reply

Your email address will not be published. Required fields are marked *